An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
NCT05254405
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG:
Brexanolone Injection [Zulresso]
Sponsor
Donald Jeffrey Newport
Collaborators
[object Object]